 |
Prevalence (%) of clinical parameters based on data from 1 references describing 7 individuals
Add new symptom/sign to this disease
List of symptoms
| Symptom/sign |
Organ system |
Percent affected |
Pubmed id |
Added on(yyyy-mm-dd) |
Edit/add reference |
| Cerebellar atrophy |
nervous |
86 % |
22522420 |
2024-05-28 |
|
| Increased blood CK |
circulatory |
57 % |
22522420 |
2024-05-17 |
|
| Cataract |
nervous |
57 % |
22522420 |
2024-05-17 |
|
| Corpus callosum thining |
nervous |
43 % |
22522420 |
2024-05-17 |
|
| Brainstem hypoplasia |
nervous |
43 % |
22522420 |
2024-05-17 |
|
| Microphthalmia |
nervous |
43 % |
22522420 |
2024-05-17 |
|
| Heterotopia |
nervous |
29 % |
22522420 |
2024-05-17 |
|
| White matter hyperintensities |
nervous |
29 % |
22522420 |
2024-05-17 |
|
| Pachygyria |
nervous |
29 % |
22522420 |
2024-05-17 |
|
| Optic nerve atrophy |
nervous |
29 % |
22522420 |
2024-05-17 |
|
| Muscle atrophy |
skeletal |
29 % |
22522420 |
2024-05-17 |
|
| Abnormal cornea |
nervous |
14 % |
22522420 |
2024-05-17 |
|
| Retinal dysplasias |
nervous |
14 % |
22522420 |
2024-05-17 |
|
| Thinning of cerebral gray matter |
nervous |
14 % |
22522420 |
2024-05-17 |
|
| Macular degeneration |
nervous |
14 % |
22522420 |
2024-05-17 |
|
| Brainstem atrophy |
nervous |
14 % |
22522420 |
2024-05-17 |
|
List of references:
ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome. Tobias Willer, Hane Lee, Mark Lommel, Takako Yoshida-Moriguchi, Daniel Beltran Valero de Bernabe, David Venzke, Sebahattin Cirak, Harry Schachter, Jiri Vajsar, Thomas Voit, Francesco Muntoni, Andrea S Loder, William B Dobyns, Thomas L Winder, Sabine Strahl, Katherine D Mathews, Stanley F Nelson, Steven A Moore, Kevin P Campbell,
Nature genetics - May 2012
|